TURKISH NEUROSURGERY, cilt.30, sa.2, ss.163-170, 2020 (SCI-Expanded, Scopus, TRDizin)
AIM: To investigate the effects of an anti-ischemic agent, mildronate, on subarachnoid hemorrhage-induced vasospasm.